Protea Designated as a Global Small Giant by Ministry of SMEs and Startups

Aiming to Expand Export Destinations to 100 Countries

Protea announced on May 21 that it has been designated as a "Global Small Giant" under the "Global Small Giant Companies 1000+ Project" led by the Ministry of SMEs and Startups.

The Global Small Giant Companies certification is a nationally recognized designation, awarded to companies with annual export performance between USD 5 million and less than USD 10 million, selected through a comprehensive evaluation of technology, growth potential, and export capacity. Designated companies receive various government support benefits, such as automatic selection for export vouchers, preferential access to policy funds, research and development (R&D) support, and preferential limits on export guarantees and insurance.

Im Gukjin, CEO of Protea, is taking a commemorative photo with Kim Woosoon, Commissioner of the Seoul Regional Small and Medium Venture Business Administration, at the 2026 Global Small Giant Company Designation Certificate Ceremony. Protea

Protea's export performance has grown tenfold over the past five years, reaching 7.8 billion won last year.

In the domestic market, Protea supplies the "PROTIA Allergy-Q 192D," which can simultaneously test for about 180 types of allergens. In overseas markets, the company offers allergy testing products that can test for 40, 60, 100, 120, or 180 types at once.

The company is also expanding its export portfolio by introducing allergy diagnostic products for companion animals and antibiotic susceptibility diagnostic products to the global market.

Protea plans to increase its export destinations from the current 82 countries to 100 and to strengthen its position in the global allergy diagnostics market by developing new products and pioneering new markets.

This content was produced with the assistance of AI translation services.